<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The actions of relaxin on the human cardiovascular system Correspondence Professor</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Roger</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
							<email>roger.summers@monash.edu</email>
							<affiliation key="aff1">
								<orgName type="department">Drug Discovery Biology</orgName>
								<orgName type="institution">Monash Institute of Pharmaceutical Sciences</orgName>
								<address>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mohsin</forename><surname>Sarwar</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Drug Discovery Biology</orgName>
								<orgName type="institution">Monash Institute of Pharmaceutical Sciences</orgName>
								<address>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xiao-Jun</forename><surname>Du</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Baker IDI Heart and Diabetes Institute</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">B</forename><surname>Dschietzig</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Medical Clinic for Cardiology and Angiology</orgName>
								<orgName type="institution">Immundiagnostik AG</orgName>
								<address>
									<addrLine>4 Campus Mitte</addrLine>
									<settlement>Bensheim, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Relaxera Pharmazeutische Gesellschaft mbH &amp; Co. KG</orgName>
								<address>
									<settlement>Bensheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Drug Discovery Biology</orgName>
								<orgName type="institution" key="instit1">Monash Institute of Pharmaceutical Sciences</orgName>
								<orgName type="institution" key="instit2">Monash University</orgName>
								<address>
									<addrLine>399 Royal Parade</addrLine>
									<postCode>3052</postCode>
									<settlement>Parkville</settlement>
									<region>Vic</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The actions of relaxin on the human cardiovascular system Correspondence Professor</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">69D24DC4D4FBD673DCD53AE5EC5C9A0C</idno>
					<idno type="DOI">10.1111/bph.v174.10/issuetoc</idno>
					<note type="submission">Received 22 February 2016; Revised 1 April 2016; Accepted 26 April 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>FGF, basic FGF</term>
					<term>BMDECs, bone marrow-derived endothelial cells</term>
					<term>CI, cardiac index</term>
					<term>CO, cardiac output</term>
					<term>ET-1, endothelin-1</term>
					<term>ECM, extracellular matrix</term>
					<term>i Ca 2+ , intracellular calcium</term>
					<term>IR, ischaemia-reperfusion</term>
					<term>mRen2, murine renin gene</term>
					<term>MI, myocardial infarction</term>
					<term>PGF, placental growth factor</term>
					<term>PVR, pulmonary vascular resistance</term>
					<term>SHR, spontaneously hypertensive rat</term>
					<term>SVR, systemic vascular resistance</term>
					<term>TIMP, tissue inhibitors of metalloproteinase</term>
					<term>TGF-β1, transforming growth factor β1</term>
					<term>VSMC, vascular smooth muscle cells</term>
					<term>VAS, visual analogue scale</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The insulin-like peptide relaxin, originally identified as a hormone of pregnancy, is now known to exert a range of pleiotropic effects including vasodilatory, anti-fibrotic, angiogenic, anti-apoptotic and anti-inflammatory effects in both males and females.</s><s>Relaxin produces these effects by binding to a cognate receptor RXFP1 and activating a variety of signalling pathways including cAMP, cGMP and MAPKs as well as by altering gene expression of TGF-β, MMPs, angiogenic growth factors and endothelin receptors.</s><s>The peptide has been shown to be effective in halting or reversing many of the adverse effects including fibrosis in animal models of cardiovascular disease including ischaemia/reperfusion injury, myocardial infarction, hypertensive heart disease and cardiomyopathy.</s><s>Relaxin given to humans is safe and produces favourable haemodynamic changes.</s><s>Serelaxin, the recombinant form of relaxin, is now in extended phase III clinical trials for the treatment of acute heart failure.</s><s>Previous clinical studies indicated that a 48 h infusion of relaxin improved 180 day mortality, yet the mechanism underlying this effect is not clear.</s><s>This article provides an overview of the cellular mechanism of effects of relaxin and summarizes its beneficial actions in animal models and in the clinic.</s><s>We also hypothesize potential mechanisms for the clinical efficacy of relaxin, identify current knowledge gaps and suggest new ways in which relaxin could be useful therapeutically.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Relaxin is a heterodimeric peptide hormone closely related structurally to insulin.</s><s>The major circulating form of relaxin is that produced by the RLN2 gene and is the cognate ligand for the RXFP1 receptor, a classical GPCR containing seven transmembrane spanning regions as well as a large extracellular domain with 10 leucine-rich repeats and a unique N-terminal LDL receptor type A module <ref type="bibr" target="#b83">(Hsu et al., 2002)</ref>.</s><s>Relaxin is closely related to insulin-like peptide 3, relaxin-3 and insulin-like peptide 5, which are the cognate ligands for the relaxin family peptide receptors RXFP2, RXFP3 and RXFP4 respectively <ref type="bibr" target="#b2">(Alexander et al., 2015b)</ref>.</s><s>RXFP1 mRNA and protein are found in mammalian reproductive tissues but also in the heart, arteries, kidney, lung, liver and blood cells as well as in a number of areas of the brain <ref type="bibr" target="#b46">(Dschietzig et al., 2001b;</ref><ref type="bibr" target="#b12">Bathgate et al., 2013;</ref><ref type="bibr" target="#b71">Halls et al., 2015)</ref>.</s><s>It is now recognized that relaxin acting through RXFP1 receptors has pleiotropic effects including vasodilation, anti-fibrotic, angiogenic, anti-apoptotic and antiinflammatory effects (Figure <ref type="figure">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The pleiotropic effects of relaxin</head><p><s>Relaxin, originally identified as a hormone of pregnancy, mediates many of the cardiovascular and renal adaptations of pregnancy <ref type="bibr" target="#b29">(Conrad and Shroff, 2011)</ref>.</s><s>Relaxin-neutralizing antibodies or ovariectomy prevents the rise in arterial compliance (AC) and cardiac output (CO) and the fall in systemic vascular resistance (SVR) seen in pregnant rats <ref type="bibr" target="#b36">(Debrah et al., 2006)</ref> and prevents the renal vasodilation normally observed during pregnancy <ref type="bibr" target="#b131">(Novak et al., 2001)</ref>.</s><s>These effects are also observed in non-pregnant animals <ref type="bibr" target="#b32">(Danielson et al., 1999;</ref><ref type="bibr">Conrad and Novak, 2004;</ref><ref type="bibr" target="#b34">Debrah et al., 2005a)</ref>.</s></p><p><s>Other chronic effects of relaxin include important and consistent inhibitory effects on stimulated extracellular matrix (ECM) deposition.</s><s>It inhibits proliferation and differentiation of fibroblasts into myofibroblasts (activated fibroblasts that promote ECM/collagen deposition and fibrosis) in rat cardiac <ref type="bibr" target="#b144">(Samuel et al., 2004a)</ref>, renal <ref type="bibr" target="#b117">(Masterson et al., 2004)</ref>, hepatic <ref type="bibr" target="#b170">(Williams et al., 2001)</ref> and human pulmonary tissues <ref type="bibr" target="#b165">(Unemori et al., 1996;</ref><ref type="bibr" target="#b84">Huang et al., 2001)</ref>; it also activates various ECM/collagen-degrading MMPs and inhibits tissue inhibitors of metalloproteinase (TIMP) activity <ref type="bibr" target="#b142">(Samuel et al., 2007;</ref><ref type="bibr" target="#b14">Bennett, 2009)</ref>.</s><s>Additionally, the peptide represents an important driver of VEGF-related angiogenesis and wound healing <ref type="bibr" target="#b163">(Unemori et al., 1992;</ref><ref type="bibr" target="#b164">Unemori et al., 2000)</ref>.</s></p><p><s>Relaxin has anti-apoptotic and anti-hypertrophic effects in human trophoblasts <ref type="bibr" target="#b109">(Lodhi et al., 2013)</ref>, human osteosarcomas <ref type="bibr" target="#b110">(Ma et al., 2013a)</ref>, epithelial and stromal cells <ref type="bibr" target="#b104">(Lee et al., 2005)</ref> and rodent cardiomyocytes <ref type="bibr" target="#b126">(Moore et al., 2007;</ref><ref type="bibr" target="#b140">Samuel et al., 2011)</ref>.</s><s>These anti-apoptotic effects of relaxin are dependent on RXFP1 receptors as the peptide has no apoptotic effects in RXFP1 À/À mice <ref type="bibr" target="#b175">(Yao et al., 2009)</ref>.</s></p><p><s>Relaxin has anti-inflammatory effects in humans and animals.</s><s>It inhibits vascular inflammation by inhibiting TNFα-induced expression of vascular cell adhesion molecule, platelet endothelial cell adhesion molecule and the chemokine CCL2 <ref type="bibr" target="#b19">(Brecht et al., 2011)</ref>.</s><s>It furthermore inhibits markers of inflammation in an NO-dependent manner by attenuating activation of neutrophils <ref type="bibr" target="#b5">(Bani et al., 2002;</ref><ref type="bibr" target="#b115">Masini et al., 2004)</ref> and basophils <ref type="bibr" target="#b5">(Bani et al., 2002)</ref> and by inhibiting histamine release from mast cells <ref type="bibr" target="#b114">(Masini et al., 1995)</ref>.</s><s>Relaxin also inhibits the aggregation of isolated human and rabbit platelets <ref type="bibr" target="#b6">(Bani et al., 1995a)</ref> and decreases the number of cir-THP-1 and MCF-7 cells; rat renal and cardiac fibroblasts; rat heart; human endothelial and smooth muscle cells; and fibroblasts from human arteries and veins <ref type="bibr" target="#b100">(Kompa et al., 2002;</ref><ref type="bibr" target="#b128">Nguyen and Dessauer, 2005a;</ref><ref type="bibr" target="#b72">Halls et al., 2009;</ref><ref type="bibr" target="#b80">Horton et al., 2011)</ref>.</s><s>The characteristics of relaxin-mediated cAMP accumulation are dependent on the cellular background.</s><s>In HEK-RXFP1 cells, there is increased cAMP accumulation associated with coupling to Gα s modulated by Gα OB and a delayed increase in cAMP mediated through Gα i3 <ref type="bibr" target="#b70">(Halls et al., 2006)</ref>, βγ subunits, PI3K and translocation of PKC-ζ to the cell membrane to activate AC <ref type="bibr" target="#b129">(Nguyen and Dessauer, 2005b;</ref><ref type="bibr" target="#b70">Halls et al., 2006)</ref>.</s><s>The Gα i3 -Gβγ-PI3K-PKC-ζ pathway also operates in THP-1 cells, in human endothelial and smooth muscle cells and in rat and human cardiac fibroblasts but is missing in rat renal fibroblasts and Colo16 cells, where Pertussis toxin pretreatment enhances relaxin-mediated cAMP accumulation <ref type="bibr" target="#b72">(Halls et al., 2009)</ref>.</s></p><p><s>NO and cGMP.</s><s>Relaxin utilizes NO to produce vasodilation in vitro <ref type="bibr" target="#b10">(Bani-Sacchi et al., 1995;</ref><ref type="bibr" target="#b7">Bani et al., 1998a;</ref><ref type="bibr" target="#b120">McGuane et al., 2011b)</ref> and in vivo <ref type="bibr" target="#b91">(Jeyabalan et al., 2003;</ref><ref type="bibr" target="#b29">Conrad and Shroff, 2011)</ref>.</s><s>In vitro, relaxin rapidly activates the NO/cGMP pathway in vascular smooth muscle, coronary artery endothelium, bovine aortic smooth muscle, human breast cancer cells, perfused guinea pig and rat hearts and mouse uterus <ref type="bibr" target="#b10">(Bani-Sacchi et al., 1995;</ref><ref type="bibr" target="#b8">Bani et al., 1995b;</ref><ref type="bibr">Bani et al., 1998a,b;</ref><ref type="bibr" target="#b54">Failli et al., 2002;</ref><ref type="bibr" target="#b116">Masini et al., 2002)</ref> as well as rat cardiac <ref type="bibr" target="#b144">(Samuel et al., 2004a)</ref> and renal <ref type="bibr" target="#b124">(Mookerjee et al., 2009;</ref><ref type="bibr" target="#b24">Chow et al., 2014)</ref> fibroblasts.</s><s>This is achieved by increasing the activity and/or expression of NOS.</s><s>Relaxin interacts with all three NOS subtypes: endothelial NOS (eNOS) <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref>, inducible NOS (iNOS) <ref type="bibr" target="#b54">(Failli et al., 2002;</ref><ref type="bibr" target="#b137">Quattrone et al., 2004)</ref> and neuronal NOS (nNOS) <ref type="bibr" target="#b23">(Chow et al., 2012;</ref><ref type="bibr" target="#b124">Mookerjee et al., 2009)</ref>, to increase NO production, although the interaction is not well understood and is highly species-and tissuedependent.</s><s>Vasodilatory responses and phosphorylation of eNOS in human coronary artery endothelial cells to acutely administered relaxin are attenuated by inhibition of Gα i/o coupling to PI3K, PKB/Akt, indicating that NO/cGMP production is dependent on Gα i/o , PI3K, Akt and NOS (Figure <ref type="figure">2</ref>) <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref>.</s><s>However, in rat renal fibroblasts, chronic relaxin over 72 h promotes nNOSderived NO/cGMP signalling through Gα s and Gα OB</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 2</head><p><s>Mechanisms involved in short-term (minutes) relaxin-mediated signal transduction in human primary vascular cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 1</head><p><s>The tissue distribution of RXFP1 receptors and the physiology of relaxin in humans.</s><s>Relaxin has vasodilatory, anti-fibrotic and remodelling effects in various reproductive and non-reproductive organs.</s><s><ref type="bibr" target="#b124">(Mookerjee et al., 2009;</ref><ref type="bibr" target="#b24">Chow et al., 2014)</ref>.</s><s>In vivo, the NOS/NO/cGMP pathway is critical for relaxin-induced vasodilation and cardioprotection.</s><s>Relaxin protects rat lungs after ischaemia-reperfusion (IR) injury through iNOS induction <ref type="bibr" target="#b4">(Alexiou et al., 2013)</ref>, reduces infarct size in rat brains by eNOS activation <ref type="bibr" target="#b171">(Wilson et al., 2006)</ref> and reduces cardiac infarct size in the pig through a NOS-dependent mechanism <ref type="bibr" target="#b113">(Masini et al., 1997)</ref> but also reduces fibrosis when given chronically in a bleomycin-induced lung fibrosis mouse model through an NO/cGMP-dependent pathway <ref type="bibr" target="#b85">(Huang et al., 2011)</ref>.</s></p><p><s>MAPKs.</s><s>The MAPK ERK1/2 inhibits apoptosis and promotes cell survival and is likely to play key roles in cardiomyocyte survival in heart failure (HF) <ref type="bibr" target="#b21">(Bueno and Molkentin, 2002)</ref>.</s><s>Relaxin stimulation causes a transient increase in ERK1/2 phosphorylation (pERK1/2) in HEK-RXFP1 cells, THP-1 cells <ref type="bibr" target="#b128">(Nguyen and Dessauer, 2005a)</ref>, HeLa cells <ref type="bibr" target="#b42">(Dschietzig et al., 2003)</ref>, human endometrial stromal cells <ref type="bibr" target="#b180">(Zhang et al., 2002)</ref>, rat renal fibroblasts <ref type="bibr" target="#b23">(Chow et al., 2012)</ref>, human smooth muscle cells <ref type="bibr" target="#b180">(Zhang et al., 2002)</ref> and fibrocartilaginous cells <ref type="bibr" target="#b0">(Ahmad et al., 2012)</ref>.</s><s>A more prolonged pERK1/2 response occurs in HUVECs and immortalised HUVECs (Eahy926 cells) <ref type="bibr" target="#b42">(Dschietzig et al., 2003;</ref><ref type="bibr" target="#b38">Dschietzig et al., 2009a)</ref>.</s><s>Relaxin rapidly increases pERK1/2 in human vascular cells in a Gα i -and PI3Kdependent manner <ref type="bibr" target="#b148">(Sarwar et al., 2015;</ref><ref type="bibr"></ref> Figure <ref type="figure">2</ref>), and this likely mediates the anti-apoptotic and cardiac cell survival effects of relaxin in humans.</s><s>Other MAPKs such as p38MAPK are also activated, but this response is dependent on the cellular background.</s><s>Thus, relaxin increases p38MAPK in human vascular smooth muscle cells (VSMC) but not in HUVEC or HeLa cells <ref type="bibr" target="#b42">(Dschietzig et al., 2003)</ref>, whereas in human renal fibroblasts, relaxin does not affect pERK1/2, p38MAPK or pJNK <ref type="bibr" target="#b74">(Heeg et al., 2005)</ref>.</s></p><p><s>Calcium.</s><s>Relaxin has no direct effect on basal intracellular calcium ( i Ca 2+ ) levels but inhibits agonist (angiotensin II (Ang II) and thrombin)-mediated i Ca 2+ in rat VSMC and endothelial cells, rat coronary artery endothelial cells, bovine aortic VSMC and guinea pig hearts <ref type="bibr" target="#b9">(Bani et al., 1998b;</ref><ref type="bibr" target="#b54">Failli et al., 2002;</ref><ref type="bibr" target="#b116">Masini et al., 2002)</ref>, perhaps reflecting that RXFP1 receptors are not Gα q coupled.</s><s>Although Gα i coupling increases i Ca 2+ <ref type="bibr" target="#b98">(Kiselyov et al., 2003)</ref>, this does not occur with the relaxin/RXFP1receptor system, as relaxin does not affect i Ca 2+ signalling.</s><s>Relaxin most likely acts as a physiological antagonist by producing vasodilator effects that counteract the vasoconstrictor actions of Ang II and endothelin-1 (ET-1) that cause i Ca 2+ release via their respective receptors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chronic changes produced by relaxin</head><p><s>Matrix metalloproteinases.</s><s>The anti-fibrotic effects observed with chronically administered relaxin include inhibition of transforming growth factor β1 (TGF-β1), promotion of the expression and/or activity of ECM/collagen-degrading MMPs and inhibition of TIMP activity <ref type="bibr" target="#b142">(Samuel et al., 2007)</ref>.</s><s>In vitro relaxin increases MMP-2 activity in human renal <ref type="bibr" target="#b74">(Heeg et al., 2005)</ref> and rat cardiac <ref type="bibr" target="#b144">(Samuel et al., 2004a;</ref><ref type="bibr" target="#b74">Heeg et al., 2005)</ref> and renal <ref type="bibr" target="#b24">(Chow et al., 2014)</ref> fibroblasts, whereas it increases MMP-9 activity in THP-1 cells, rat renal fibroblasts and temporomandibular joint (TMJ) cells <ref type="bibr" target="#b74">(Heeg et al., 2005;</ref><ref type="bibr" target="#b75">Ho et al., 2007;</ref><ref type="bibr" target="#b0">Ahmad et al., 2012;</ref><ref type="bibr" target="#b24">Chow et al., 2014)</ref>.</s><s>Relaxininduced activation of MMP-2, MMP-9 and MMP-13 in human and rat renal fibroblasts is associated with iNOS-induced NO production <ref type="bibr" target="#b23">(Chow et al., 2012)</ref> and inhibition of Smad-2 phosphorylation and thus TGF-β1 activation <ref type="bibr" target="#b74">(Heeg et al., 2005;</ref><ref type="bibr" target="#b124">Mookerjee et al., 2009)</ref>.</s><s>Relaxin also interacts with other MMPs in a tissue-dependent manner because in TMJ fibrocartilaginous cells, relaxin increases MMP-1, MMP-9 and MMP-13 activity but only increases MMP-13 activity in rat ventricular fibroblasts <ref type="bibr" target="#b94">(Kapila et al., 2009;</ref><ref type="bibr" target="#b81">Hossain et al., 2011;</ref><ref type="bibr" target="#b0">Ahmad et al., 2012)</ref>.</s><s>In human dermal fibroblasts and rat renal myofibroblasts, relaxin increased MMP-2 and MMP-9 by a mechanism involving RXFP1 receptors, pERK1/2 and NO/cGMP (Figures <ref type="figure">2 and 3</ref>) <ref type="bibr" target="#b23">(Chow et al., 2012)</ref>.</s><s>Similarly, in fibrocartilaginous cells, relaxin increased MMP-9 and MMP-13 by stimulating RXFP1 receptors and activating PI3K, Akt, ERK and PKC-ζ and the transcription factors Elk-1 and c-fos <ref type="bibr" target="#b0">(Ahmad et al., 2012)</ref>.</s><s>NF-kB also has a role in relaxin-mediated MMP-9 activation in human THP-1 and fibrocartilaginous cells <ref type="bibr" target="#b75">(Ho et al., 2007;</ref><ref type="bibr" target="#b0">Ahmad et al., 2012)</ref>.</s></p><p><s>Angiogenic growth factors.</s><s>Involvement of growth factors and cytokines in the angiogenic effects of chronic relaxin is conflicting and likely to be tissue and cell specific.</s><s>In THP-1 cells, relaxin increases the expression of VEGF (VEGF 165 and VEGF 121 ) and basic FGF (b-FGF) and causes angiogenesis at ischaemic wound sites in rodents <ref type="bibr" target="#b164">(Unemori et al., 2000)</ref>.</s><s>Relaxin stimulates VEGF production in human endometrial cells <ref type="bibr" target="#b162">(Unemori et al., 1999)</ref>, Saos-2 cells <ref type="bibr" target="#b111">(Ma et al., 2013b)</ref>, THP-1 cells <ref type="bibr" target="#b164">(Unemori et al., 2000)</ref> and human endothelial cells <ref type="bibr" target="#b163">(Unemori et al., 1992)</ref>.</s><s>The mechanism involves cAMP in normal human endometrial cells where relaxin induces VEGF expression in a cAMP-dependent manner without affecting b-FGF, TGF-β1 and placental growth factor (PGF) (Figures <ref type="figure">2 and 3</ref>) <ref type="bibr" target="#b162">(Unemori et al., 1999)</ref>.</s><s>Although VEGF receptor inhibitors prevent relaxin-induced increases in GFR and decreases in renal vascular resistance without affecting mean arterial pressure <ref type="bibr" target="#b119">(McGuane et al., 2011a)</ref>, in rat small renal arteries, SU5416 increases relaxin-mediated vasodilation <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref>.</s><s>These apparently contradictory effects may relate to actions of SU5416 other than VEGF receptor blockade that include inhibition of the tyrosine kinases FLT-3 and RET and other protein kinases such as c-Kit and Met <ref type="bibr" target="#b123">(Mologni et al., 2006)</ref>.</s><s>However, VEGF and PGF neutralization prevents relaxin-mediated inhibition of myogenic constriction in mouse and rat small renal and human subcutaneous arteries <ref type="bibr" target="#b119">(McGuane et al., 2011a)</ref>, suggesting that VEGF and PGF may have a role in relaxin-mediated vasodilation.</s></p><p><s>In mice, relaxin increases circulating levels of bone marrow-derived endothelial cells (BMDECs) that facilitate angiogenesis and contribute to repair of vascular endothelium.</s><s>BMDECs are recruited to the site of angiogenesis where relaxin promotes vasculogenesis by RXFP1 receptor activation, leading to NO generation and PI3K and Akt signalling <ref type="bibr" target="#b152">(Segal et al., 2012;</ref><ref type="bibr" target="#b111">Ma et al., 2013b)</ref>.</s><s>This may explain the healing properties of relaxin because chronic administration in diabetic mice increases VEGF levels in the wound area and promotes skin recovery, an effect reversed by administration of VEGF antibodies <ref type="bibr" target="#b15">(Bitto et al., 2013)</ref>.</s></p><p><s>Endothelin receptors.</s><s>Endothelin receptors are secondary mediators in the vasodilatory responses to relaxin.</s><s>In HeLa cells, HUVECs and bovine aortic endothelial cells, but not in human VSMC, relaxin increases mRNA and protein of the ET B receptor by a Ras-independent Raf-1-MEK-1-ERK1/2 kinase cascade that activates NF-kB (Figures <ref type="figure">2 and 3</ref>), and the vasoconstrictor responses to ET-1 and ET-3 in rat aorta strips are inhibited by relaxin treatment in an ERK1/2-and ET B -dependent manner <ref type="bibr" target="#b42">(Dschietzig et al., 2003)</ref>.</s><s>The role of ET B receptors in vasodilatory responses to relaxin is strongly affected by cell and tissue background.</s><s>In small renal arteries from virgin, midterm pregnant and non-pregnant rats, relaxin has no effect on ET B receptor levels <ref type="bibr" target="#b96">(Kerchner et al., 2005)</ref>.</s><s>In lung IR injury, relaxin is protective, but the effect does not involve ET B receptors <ref type="bibr" target="#b4">(Alexiou et al., 2013)</ref>.</s><s>However, in human coronary artery endothelial cells and HUVECs but not in human aortic endothelial cells or human dermal microvascular endothelial cells, relaxin produced small and inconsistent increases expression of ET B receptors <ref type="bibr" target="#b96">(Kerchner et al., 2005)</ref>.</s><s>This apparent discrepancy was explained by the use of small rather than large arteries, no pulmonary endothelial cells and the significantly lower relaxin concentrations used in the latter study.</s><s>Furthermore, small renal arteries from relaxin-treated non-pregnant rats showed reduced myogenic reactivity, an effect not observed in mice lacking ET B receptors <ref type="bibr" target="#b91">(Jeyabalan et al., 2003)</ref>.</s><s>More recent studies with 24 and 48 h exposure to relaxin (1.68 nM) show modest but consistent increases in ET B receptors in HUVEC, human umbilical arterial smooth muscle cells and human cardiac fibroblasts and marked increases in human umbilical venous smooth muscle cells <ref type="bibr" target="#b148">(Sarwar et al., 2015)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Actions of relaxin in the cardiovascular system Relaxin targets vascular cells</head><p><s>There is evidence from preclinical and clinical studies that relaxin targets the vasculature.</s><s>In rats, chronic relaxin increases CO, global AC, renal plasma flow and GFR and reduces SVR and myogenic constriction without affecting mean arterial pressure <ref type="bibr" target="#b32">(Danielson et al., 1999;</ref><ref type="bibr">Conrad et al., 2004;</ref><ref type="bibr" target="#b34">Debrah et al., 2005a)</ref>.</s><s>Given acutely, relaxin specifically vasodilates rat mesenteric arteries, rodent small renal and mesenteric arteries <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref> and human small gluteal and subcutaneous arteries but not pulmonary resistance arteries <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref>.</s><s>Relatively little is known about the effects of relaxin on veins despite relaxant effects on</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 3</head><p><s>Effects of longer-term (hours to days) relaxin administration on expression of genes likely to influence signal transduction in human primary vascular cells.</s></p><p><s>mesenteric veins without affecting myogenic reactivity <ref type="bibr" target="#b108">(Li et al., 2005)</ref> and powerful effects on signalling in human umbilical venous smooth muscle cells <ref type="bibr" target="#b148">(Sarwar et al., 2015)</ref>.</s><s>The regionally specific effects of relaxin can be explained by differential RXFP1 receptor expression in different vascular beds.</s><s>Thus, in rats, RXFP1 receptors are highly expressed in endothelial cells of the aorta, vena cava, mesenteric artery and vein as well as in VSMC of the femoral artery and vein and small pulmonary arteries <ref type="bibr" target="#b89">(Jelinic et al., 2014)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Signal transduction pathways activated by relaxin in vascular cells</head><p><s>Relaxin given acutely causes cAMP, cGMP and pERK1/2 signalling in endothelial cells, VSMC and fibroblasts from human arteries and veins <ref type="bibr" target="#b148">(Sarwar et al., 2015)</ref>, mediated by Gα s , Gα i/o and Gα OB G-proteins and involving PI3K downstream of G-protein activation (Figure <ref type="figure">2</ref>).</s><s>These pathways likely mediate the rapid dilation observed in human subcutaneous arteries and rodent renal and mesenteric arteries where acute relaxin rapidly activates Gα i , PI3K and NOS signalling <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref>.</s><s>Longer-term relaxin also changes gene expression in endothelial cells, VSMC and fibroblasts from human arteries and veins with increased gelatinases (MMP-2 and MMP-9), ET B receptors, VEGF and NOS in most but not all cell types <ref type="bibr" target="#b148">(Sarwar et al., 2015)</ref> (Figure <ref type="figure">3</ref>).</s><s>These changes may account for the haemodynamic changes observed during pregnancy and in vivo, particularly the increase in AC and decrease in SVR (thereby improving CO) observed in pregnant <ref type="bibr" target="#b36">(Debrah et al., 2006)</ref> and non-pregnant animals <ref type="bibr">(Conrad et al., 2004)</ref>.</s><s>More importantly, these changes are likely to account for the widespread haemodynamic changes observed in patients with acute HF (AHF) treated with serelaxin <ref type="bibr" target="#b136">(Ponikowski et al., 2014)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relaxin promotes vascular cell crosstalk</head><p><s>The endothelium secretes vasoactive substances including NO, PGs and endothelium-derived hyperpolarizing factor that regulate smooth muscle tone.</s><s>Responses to relaxin were abolished in human gluteal arteries denuded of endothelium <ref type="bibr" target="#b59">(Fisher, 2009)</ref>, and in an in vitro co-culture model, the relaxin responses in VSMC were endothelium dependent and governed by expression of RXFP1 receptors in endothelial cells (Figure <ref type="figure">4</ref>) <ref type="bibr" target="#b146">(Sarwar et al., 2016)</ref>.</s></p><p><s>NO synthesis regulates relaxin-mediated crosstalk between endothelial cells and VSMC in the human vasculature (Figure <ref type="figure">4</ref>).</s><s>This is observed in vitro in human arterial/venous endothelial cells and VSMC <ref type="bibr" target="#b146">(Sarwar et al., 2016)</ref>, in vivo in conscious rats where NO inhibition abolished relaxinmediated increases in renal vasodilation <ref type="bibr" target="#b32">(Danielson et al., 1999)</ref> and in rat and guinea pig hearts where NO inhibition abolished relaxin-mediated increases in coronary flow <ref type="bibr" target="#b10">(Bani-Sacchi et al., 1995)</ref>.</s></p><p><s>Prostanoids are also involved in specific circumstances.</s><s>In human coronary artery endothelial cells but not HUVEC, relaxin promotes COX activity to cause an increase in cAMP accumulation in co-cultured smooth muscle cells <ref type="bibr" target="#b146">(Sarwar et al., 2016)</ref>.</s><s>In ex vivo human gluteal arteries, indomethacin (a non-specific COX inhibitor) almost abolished relaxinmediated vasodilation <ref type="bibr" target="#b59">(Fisher, 2009)</ref>, suggesting that, in some circumstances, there is a role for prostanoids in relaxin signal transduction.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Actions of relaxin on the heart</head><p><s>The mammalian heart contains relaxin binding sites that are exclusively found in the atrium <ref type="bibr" target="#b132">(Osheroff et al., 1992;</ref><ref type="bibr" target="#b158">Tan et al., 1999)</ref>.</s><s>Acutely administered relaxin has positive chronotropic and inotropic effects in the rat isolated perfused heart and isolated atria, with a potency greater than ET-1, Ang II or isoprenaline <ref type="bibr" target="#b93">(Kakouris et al., 1992;</ref><ref type="bibr" target="#b31">Coulson et al., 1996;</ref><ref type="bibr" target="#b161">Toth et al., 1996)</ref>.</s></p><p><s>Relaxin inhibits injury-induced hypertrophy and apoptosis in neonatal rat cardiomyocytes and increases the growth and maturation of neonatal mouse cardiomyocytes.</s><s>RXFP1 receptors are expressed in cardiac fibroblasts from several species including rodents and humans where they cause short-term and long-term changes in signal transduction <ref type="bibr" target="#b146">(Sarwar et al., 2016)</ref> (Figures <ref type="figure">2 and 3</ref>).</s><s>Relaxin also acts on the pacemaker cells of the rabbit sino-atrial node by modulating L-type Ca 2+ current to increase heart rate.</s><s>The effect of relaxin was not observed when administered following the β-adrenoceptor agonist isoprenaline or the cell permeable cAMP analogue 8-Br-cAMP that produced similar effects.</s><s>The responses to relaxin, isoprenaline and 8-Br-cAMP were blocked by the PKA inhibitor PKI, suggesting that they were all mediated by a cAMP/PKA-dependent pathway <ref type="bibr" target="#b73">(Han et al., 1994)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of relaxin in human tissues</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human blood vessels</head><p><s>In general, studies on human vessels are in concordance with mechanisms elucidated in rodents (McGuane et al.,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 4</head><p><s>Relaxin only activates endothelial cells that express cell surface RXFP1 receptors to promote cellular crosstalk between endothelial cells and smooth muscle cells involving NO and, in some endothelial cells, prostanoids.</s></p><p><s>2011a,b).</s><s>Relaxin has both acute and longer-term vasodilatory properties.</s><s>Acutely (within minutes), relaxin dilates arteries by activating eNOS <ref type="bibr" target="#b7">(Bani et al., 1998a;</ref><ref type="bibr" target="#b120">McGuane et al., 2011b;</ref><ref type="bibr" target="#b44">Dschietzig et al., 2012)</ref>, PI3K, Akt and PKA with subsequent eNOS phosphorylation at Ser 1195 , Ser 613 and Thr 495 and NO generation <ref type="bibr" target="#b120">(McGuane et al., 2011b;</ref><ref type="bibr" target="#b44">Dschietzig et al., 2012)</ref>.</s><s>Over a longer period (h), the ET B receptor mediates NO-dependent vasodilation <ref type="bibr" target="#b56">(Fernandez-Patron et al., 1999;</ref><ref type="bibr" target="#b42">Dschietzig et al., 2003)</ref>.</s><s>In mesenteric and renal resistance vessels of ~100-300 μm diameter, relaxin activates MMP-9 and later MMP-2 to generate the ET-1 peptide, ET 1-32 from its precursor, big ET-1 <ref type="bibr" target="#b91">(Jeyabalan et al., 2003)</ref>.</s><s>ET 1-32 , though a more potent vasoconstrictor than ET 1-21 in endothelium-denuded rat mesenteric arteries, preferentially interacts with the endothelial ET B receptors due to its site of generation in intact vessels <ref type="bibr" target="#b57">(Fernandez-Patron et al., 2000)</ref> and precipitates the release of NO <ref type="bibr" target="#b56">(Fernandez-Patron et al., 1999;</ref><ref type="bibr" target="#b120">McGuane et al., 2011b)</ref>.</s><s>VEGF and PGF are also involved in sustained vasodilation, but the precise mechanism involved is still obscure; the VEGF and PGF effects appear to be located downstream of MMPs and initiated by MMP-induced release of matrix-bound angiogenic factors <ref type="bibr" target="#b120">(McGuane et al., 2011b)</ref>.</s></p><p><s>An alternative mechanism in larger vessels and the pulmonary circulation is relaxin-induced up-regulation of endothelial ET B receptors (see above), which expression of RXFP1 receptors mediates NO production and, equally importantly, ET-1 clearance <ref type="bibr">(Dschietzig et al., 2001a,b;</ref><ref type="bibr" target="#b42">Dschietzig et al., 2003)</ref>.</s><s>Finally, relaxin promotes angiogenesis both in humans and in rodents <ref type="bibr" target="#b162">(Unemori et al., 1999;</ref><ref type="bibr" target="#b164">Unemori et al., 2000)</ref> by inducing the synthesis of VEGF and b-FGF.</s><s>This may serve to improve tissue and organ perfusion in the long term.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human heart</head><p><s>In contrast to the evidence in rodents, little information is available regarding human myocardial tissue.</s><s>Immunohistochemical studies <ref type="bibr" target="#b46">(Dschietzig et al., 2001b)</ref> of left ventricle from patients with end-stage HF indicate relaxin expression in interstitial cells and cardiomyocytes.</s><s>The expression of RXFP1 receptors has been described in human cardiac fibroblasts <ref type="bibr" target="#b148">(Sarwar et al., 2015)</ref> and cardiomyocytes.</s><s>In human atrial and ventricular samples obtained from donor and terminally failing explanted hearts <ref type="bibr" target="#b37">(Dschietzig et al., 2011)</ref>, relaxin addition evoked a potent inotropic effect in atrial (EC 50 below 1 nM), but not ventricular, myocardium from both normal and failing hearts.</s><s>This effect critically involves PKA and inhibition of the rapidly inactivating potassium outward current, I to .</s><s>Additionally, the contribution of Gα i3 -PI3K signalling clearly increases in failing human atria, in accord with Gα i/o up-regulation in chronic HF (CHF) <ref type="bibr" target="#b53">(Eschenhagen et al., 1992)</ref>.</s><s>RXFP1 receptors were expressed in atrial, but not ventricular, myocardium from both control and failing hearts.</s></p><p><s>Many questions remain regarding the role of the relaxin system in human myocardium including whether there is expression of RXFP1 receptors in adult ventricular cardiomyocytes and which of the canonical and noncanonical signalling pathways, apart from Gα i3 -PI3K, are active and how they are regulated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Haemodynamic effects of relaxin in the cardiovascular system</head><p><s>Haemodynamic effects in vivo: vascular actions Relaxin appears to have a facilitatory role in cardiovascular adaptation during pregnancy but is not essential at least in the mouse since a majority of relaxin-1 knockout (KO) mice produce litters <ref type="bibr" target="#b182">(Zhao et al., 1999)</ref>.</s><s>Reduction in SVR in pregnant women is partially attributable to the vasodilatory action of elevated circulatory levels of relaxin <ref type="bibr" target="#b154">(Sherwood, 2004)</ref>.</s><s>In rodents, acute or chronic relaxin induces vasodilatation, reduced BP, a decline in arterial stiffness, reduction in SVR and an increase in CO and renal blood flow <ref type="bibr">(Conrad and Novak, 2004)</ref>.</s><s>Haemodynamic changes seen during pregnancy and with relaxin administration are similar.</s><s>There is a sustained reduction of vascular resistance following a bolus injection of relaxin, involving bradykinin-and prostacyclinmediated vasodilatation <ref type="bibr" target="#b107">(Leo et al., 2014b)</ref>.</s><s>Relaxin (up to 6 h) reduced SVR and increased CO in hypertensive rats chronically infused with Ang II, while in an spontaneously hypertensive rat (SHR) model, similar haemodynamic effects were evident only after relaxin therapy for several days <ref type="bibr" target="#b35">(Debrah et al., 2005b)</ref>.</s><s>Whereas increased CO was not reported by other studies, chronic relaxin therapy for 2 weeks reduced large artery stiffness by lowering vascular collagen content in aged SHR <ref type="bibr" target="#b172">(Xu et al., 2010)</ref>.</s><s>Collectively, these preclinical findings indicate that several mechanisms are responsible for the reduction in vascular resistance following acute and chronic relaxin therapy <ref type="bibr" target="#b48">(Du et al., 2014)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Haemodynamic effects in vivo: cardiac actions</head><p><s>In humans, unlike rodents, administration of relaxin even at high doses did not increase heart rate <ref type="bibr" target="#b136">(Ponikowski et al., 2014)</ref>, perhaps reflecting lower expression of RXFP1 receptors in human heart, relative to rodents.</s><s>The inotropic action of relaxin involves both Gα s modulated by Gα OB <ref type="bibr" target="#b100">(Kompa et al., 2002)</ref>, which also facilitates PKA signalling by activation of the Gα i3 -PI3K pathway <ref type="bibr" target="#b71">(Halls et al., 2015)</ref>.</s><s>In isolated myofilaments, relaxin activates PKC/Ca 2+ signalling, leading to positive inotropy <ref type="bibr" target="#b153">(Shaw et al., 2009)</ref>.</s><s>In failing and nonfailing human atria, relaxin increased contractile force, by signalling that is PKA-dependent and negatively regulated by Gα i <ref type="bibr" target="#b37">(Dschietzig et al., 2011)</ref>.</s><s>There is no evidence for a ventricular inotropic action of relaxin in rodents in vivo <ref type="bibr" target="#b105">(Lekgabe et al., 2005;</ref><ref type="bibr" target="#b172">Xu et al., 2010;</ref><ref type="bibr" target="#b140">Samuel et al., 2011)</ref>.</s><s>Collectively, studies in atrial tissues from rodents have convincingly shown chronotropic and inotropic actions of relaxin.</s><s>In humans, the cardiac index (CI) was unchanged by relaxin treatment although afterload was reduced <ref type="bibr" target="#b136">(Ponikowski et al., 2014)</ref> and, apparently, relaxin does not produce inotropy in ventricular myocardium nor increase heart rate in human hearts.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Studies in models lacking RXFP1 receptors or relaxin (KO models)</head><p><s>The male but not the female relaxin KO mouse displays widespread organ fibrosis involving the reproductive system, nipples, skin, lungs, heart and kidney, with treatment with relaxin for up to 2 weeks able to reverse established fibrosis in many organs and tissues, including the heart <ref type="bibr" target="#b183">(Zhao et al., 2000;</ref><ref type="bibr" target="#b49">Du et al., 2003;</ref><ref type="bibr" target="#b143">Samuel et al., 2003;</ref><ref type="bibr">Samuel et al., 2004a, b)</ref>.</s><s>Relaxin influences vascular proliferation in the endometrium, is associated with increased regional blood flow during pregnancy and promotes uterine and placental growth.</s><s>These adaptive changes are significantly attenuated in relaxin-1 KO mice and reversed by relaxin treatment <ref type="bibr" target="#b66">(Gooi et al., 2013)</ref>.</s><s>Male relaxin KO mice display reduced compliance of resistance arteries (renal, uterus, mesentery and femoral arteries) and an attenuated vasodilatory response, implying that endogenous relaxin is required to maintain normal vascular structure and function <ref type="bibr" target="#b66">(Gooi et al., 2013;</ref><ref type="bibr" target="#b106">Leo et al., 2014a;</ref><ref type="bibr" target="#b90">Jelinic et al., 2015;</ref><ref type="bibr" target="#b127">Ng et al., 2015)</ref>.</s></p><p><s>RXFP1 receptors comprise the major type of relaxin receptor in the cardiovascular system <ref type="bibr" target="#b12">(Bathgate et al., 2013;</ref><ref type="bibr" target="#b71">Halls et al., 2015)</ref>.</s><s>In RXFP1 receptor KO mice, relaxininduced increases in NO production by endothelial cells were abolished <ref type="bibr" target="#b152">(Segal et al., 2012)</ref>.</s><s>No reduction in tissue collagen content and remodelling of the reproductive tract was seen in conditional RXFP1 receptor KO mice, a phenotype similar to that of relaxin KO mice <ref type="bibr" target="#b102">(Krajnc-Franken et al., 2004;</ref><ref type="bibr" target="#b92">Kaftanovskaya et al., 2015)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relaxin in animal models of cardiovascular disease</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IR and myocardial infarction (MI)</head><p><s>Following cardiac IR, the injured myocardium displays sequential cell death, microvascular damage, innate immune response and subsequent reparative and/or reactive myocardial fibrosis which is limited by relaxin.</s><s>In guinea pigs, rats and pigs, reduction in myocardial injury by relaxin administered prior to reperfusion was associated with attenuated Ca 2+ overload, oxidative stress, histamine release or inflammatory cell infiltration <ref type="bibr" target="#b113">(Masini et al., 1997;</ref><ref type="bibr" target="#b9">Bani et al., 1998b;</ref><ref type="bibr" target="#b61">Formigli et al., 2007)</ref>.</s><s>In the porcine IR model, treatment with relaxin or regional delivery of myoblasts transfected with the relaxin gene improved viability of engrafted myoblasts and improved healing <ref type="bibr" target="#b60">(Formigli et al., 2005;</ref><ref type="bibr" target="#b61">Formigli et al., 2007)</ref>.</s><s>Interestingly, the onset of ventricular arrhythmias during acute IR was reduced in relaxintreated rat or porcine hearts, likely to be due to reduced myocardial injury <ref type="bibr" target="#b9">(Bani et al., 1998b;</ref><ref type="bibr" target="#b130">Nistri et al., 2008)</ref>.</s><s>In vitro studies show that relaxin protects against cardiomyocyte apoptotic death induced by oxidative stress <ref type="bibr" target="#b126">(Moore et al., 2007)</ref>, hypoxia-reoxygenation <ref type="bibr" target="#b16">(Boccalini et al., 2015)</ref> or high glucose exposure <ref type="bibr" target="#b181">(Zhang et al., 2015)</ref> and involved activation of Akt together with increased Bcl-2/Bax ratio, Notch-1 activation or suppressed endoplasmic reticulum (ER) stress.</s></p><p><s>In myocardial ischaemia, microvascular damage associated with regional inflammation and regional leukocyte interaction with vascular endothelial cells represents a pivotal part of overall cardiac injury <ref type="bibr" target="#b99">(Kloner, 2011)</ref>.</s><s>In cultured endothelial cells, exposure to cytokines, inflammatory signalling and leukocyte adhesion were attenuated by relaxin <ref type="bibr" target="#b19">(Brecht et al., 2011)</ref>.</s><s>In the pig IR model <ref type="bibr" target="#b61">(Formigli et al., 2007)</ref>, the anti-fibrotic effect was associated with a reduction in infarct size, while in the mouse MI model (without reperfusion) <ref type="bibr" target="#b140">(Samuel et al., 2011)</ref>, infarct size was unchanged, and yet fibrotic healing was attenuated by relaxin without adverse influence on the extent of post-infarct ventricular remodelling and function.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hypertensive heart disease</head><p><s>The effects of relaxin have been studied in rodent models of hypertension such as SHR, drug-induced renal injury, transgenic expression of murine renin gene (mRen2) plus diabetes or hypertension induced by chronic infusion of Ang II.</s><s>In SHR or rats with Ang II-induced hypertension, relaxin therapy (1-7 days) reduced pulmonary vascular resistance (PVR) and vascular stiffness and increased renal blood flow and CO, leading to unchanged mean BP <ref type="bibr" target="#b35">(Debrah et al., 2005b)</ref> with the response to relaxin being quicker in Ang II than in SHR models.</s><s>In SHR rats with left ventricular hypertrophy, endogenous myocardial relaxin mRNA and protein levels were higher than in age-matched Wistar control rats and correlated inversely with left atrial and left ventricular mass index <ref type="bibr" target="#b39">(Dschietzig et al., 2005)</ref>.</s><s>While this was supported by in vitro findings showing inhibition of cardiomyocyte hypertrophy induced by a fibroblast-conditioned medium <ref type="bibr" target="#b126">(Moore et al., 2007)</ref>, other in vivo studies on elderly SHR did not show changes in heart weight following chronic relaxin treatment for 2 weeks <ref type="bibr" target="#b105">(Lekgabe et al., 2005;</ref><ref type="bibr" target="#b172">Xu et al., 2010)</ref>.</s></p><p><s>Studies in 9-month-old SHRs provided strong evidence for anti-fibrotic effects of relaxin, and treatment for 2 weeks (at 500 μg • kg À1 • day À1 ) effectively reduced cardiac and renal fibrosis <ref type="bibr" target="#b105">(Lekgabe et al., 2005)</ref>.</s><s>Reduced atrial fibrosis following 2 week relaxin therapy <ref type="bibr" target="#b133">(Parikh et al., 2013)</ref> and, in 17-monthold SHRs, improved large artery compliance, measured in vitro and in vivo, together with a significant reduction in arterial collagen content were observed <ref type="bibr" target="#b172">(Xu et al., 2010)</ref>.</s></p><p><s>In the salt-sensitive Dahl rat, relaxin attenuated the rise in BP and increased renal nNOS and eNOS <ref type="bibr" target="#b178">(Yoshida et al., 2011)</ref>, and selective inhibition of the three NOS isoforms blocked the anti-hypertensive effects of relaxin.</s><s>Relaxin for 6 weeks significantly decreased systolic BP, glomerular and tubulointerstitial changes and TGF-β signalling.</s><s>Relaxin also ameliorated renal ischaemic reperfusion injury, improved renal function and reduced circulating and renal expression of TNF-α <ref type="bibr" target="#b177">(Yoshida et al., 2013)</ref>.</s><s>In rats with renal injury caused by bromoethylamine or reduced renal mass, relaxin for 4 weeks preserved renal function, improved renal creatinine clearance and ameliorated proteinuria, oxidative stress and renal fibrosis, which occur together with a reduction or absence of renal hypertension <ref type="bibr" target="#b63">(Garber et al., 2001;</ref><ref type="bibr" target="#b62">Garber et al., 2003)</ref>.</s><s>Ang II infusion into rats caused hypertension, albuminuria, glomerular sclerosis and enhanced oxidative stress, which were improved by relaxin for 2weeks.</s><s>These effects were abolished by L-NAME, indicating an NO-dependent mechanism <ref type="bibr" target="#b150">(Sasser et al., 2011)</ref>.</s></p><p><s>Chronic relaxin was ineffective in rats with dual transgenic expression of mRen2 and angiotensinogen, early onset of hypertension, rapid development of organ damage (cardiomyocyte hypertrophy, loss of glomeruli, fibrosis, renal damage and severe diastolic dysfunction with preserved systolic function) and early premature death (over 70% by week 7) <ref type="bibr" target="#b69">(Haase et al., 2014)</ref>.</s><s>This severe and rapidly developing model makes testing therapeutic efficacy difficult, and in addition, the plasma levels of relaxin in this model may have been suboptimal.</s><s>Considering the reciprocal effects of cardiac-renal injury or dysfunction <ref type="bibr" target="#b18">(Braam et al., 2014)</ref>, further research is warranted to simultaneously investigate effects of relaxin on cardiac and renal injury in animal models of disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cardiomyopathy</head><p><s>Preclinical studies in rodents have used cardiomyopathy induced by chronic treatment with the β-adrenoceptor agonist isoprenaline or transgenic overexpression of human β 2 -adrenoceptors <ref type="bibr" target="#b13">(Bathgate et al., 2008;</ref><ref type="bibr" target="#b81">Hossain et al., 2011;</ref><ref type="bibr" target="#b139">Samuel et al., 2014)</ref>.</s><s>In the isoprenaline model in rats, relaxin administered with or after isoprenaline administration protected hearts against injury measured by levels of circulating biomarkers and decreased cardiac fibrosis <ref type="bibr" target="#b179">(Zhang et al., 2005;</ref><ref type="bibr" target="#b139">Samuel et al., 2014)</ref>.</s><s>Comparison of the anti-fibrotic efficacy of relaxin and the ACE inhibitor enalapril in mice with cardiac fibrosis induced by isoprenaline showed that co-administered relaxin or enalapril for 17 days effectively reduced cardiac fibrosis with relaxin displaying better efficacy.</s><s>Delayed treatment with relaxin was also effective.</s></p><p><s>In mRen2 hypertensive rats with streptozotocin-induced diabetes, relaxin therapy for 2 weeks reduced cardiac fibrosis and suppressed fibroblast proliferation and TIMP-1 activity <ref type="bibr" target="#b141">(Samuel et al., 2008)</ref>.</s><s>In mice with type 2 diabetes by highfat diet feeding for 13 weeks, relaxin administration over the last 3 weeks reduced fasting glucose level, improved insulin sensitivity, restored endothelial-dependent vasodilatation and reduced cardiac and hepatic fibrosis <ref type="bibr" target="#b17">(Bonner et al., 2013)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical studies with relaxin</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CHF and AHF</head><p><s>The first dose-finding trial in patients with stable systolic CHF <ref type="bibr" target="#b47">(Dschietzig et al., 2009b)</ref> indicated that relaxin infusion (10-960 μg • kg À1 • day À1 ) for up to 24 h was safe and evoked favourable haemodynamic changes.</s><s>Thus, it elevated CI without affecting heart rate; decreased pulmonary capillary wedge pressure, SVR and PVR; and did not significantly alter systolic BP/mean BP or right atrial pressure.</s><s>Haemodynamic changes generally started within 45-60 min.</s><s>Pharmacokinetics in stable patients with systolic CHF and impaired renal function <ref type="bibr" target="#b167">(Voors et al., 2014)</ref> showed that relaxin (30 μg • kg À1 • day À1 over 24 h) did not change systolic BP compared with placebo.</s><s>In AHF patients, who usually present with systolic BP higher than in stable CHF patients <ref type="bibr" target="#b65">(Gheorghiade et al., 2006)</ref>, systolic BP was decreased by relaxin with patients with higher initial BP experiencing larger effects <ref type="bibr" target="#b159">(Teerlink et al., 2013;</ref><ref type="bibr" target="#b168">Voors et al., 2011)</ref>.</s><s>This suggests a self-limiting effect on BPadvantageous for organ protection during AHF <ref type="bibr" target="#b168">(Voors et al., 2011)</ref>.</s></p><p><s>In a haemodynamic study in AHF patients <ref type="bibr" target="#b136">(Ponikowski et al., 2014)</ref>, the changes with relaxin (30 μg • kg À1 • day À1 ) confirmed the findings of the pilot trial in stable CHF <ref type="bibr" target="#b47">(Dschietzig et al., 2009b)</ref>, with the significant exception of CI being unchanged.</s><s>One explanation may be that the high adrenergic drive usually seen in dyspnoeic AHF patients would subside as soon as pulmonary congestion is relieved by relaxin, so introducing a confounder regarding CI.</s><s>In addition, in AHF patients, urine output and fluid balance are not controlled, and as these are improved by relaxin, the more negative volume balance may have affected CI.</s><s>The Pre-RELAX-AHF trial <ref type="bibr" target="#b160">(Teerlink et al., 2009)</ref> identified the optimal dose of serelaxin, 30 μg • kg À1 • day À1 , and confirmed the safety of the drug as well as several trends towards beneficial outcomes.</s></p><p><s>To date, the phase III RELAX-AHF trial involving more than 1100 patients is the largest cardiovascular relaxin trial <ref type="bibr" target="#b159">(Teerlink et al., 2013)</ref>.</s><s>Major inclusion criteria included dyspnoea at rest or on minimal exertion, pulmonary congestion on chest radiograph, elevated levels of B-type natriuretic peptides, mild to moderate renal dysfunction, systolic BP exceeding 125 mmHg, enrolment within 16 h of hospital admission and administration of ≥40 mg of furosemide before enrolment.</s><s>Patients with acute coronary syndrome were excluded, and dose reductions of relaxin upon excessive systolic BP drops were pre-specified.</s><s>The primary end points were dyspnoea relief measured as improvement on visual analogue scale (VAS) on day 5, as well as on the Likert scale after 6, 12, and 24 h of therapy.</s><s>The secondary end points included mortality and re-hospitalization rates within 60 days.</s><s>Among the tertiary end points, 180-day mortality and different safety assessments were pre-specified.</s><s>Of note, mean systolic BP at baseline was 142 mmHg, higher than in any previous AHF study, ~40% of all patients had atrial fibrillation, and ~45% showed an ejection fraction &gt;40%.</s><s>The mean time to inclusion was uniquely short (8 h).</s><s>RELAX met one primary end point, the improvement on VAS, but failed to meet the second, related to the Likert scale.</s><s>All secondary end points showed a neutral outcome.</s><s>Multiple, statistically unadjusted, comparisons indicated less administration of intravenous diuretics; less worsening of renal function and worsening of HF before day 14; and less dyspnoea, oedema and rales in the rhRlx group.</s><s>The effects of relaxin were not dependent on certain subgroups of the study population <ref type="bibr" target="#b122">(Metra et al., 2013b)</ref>.</s></p><p><s>A major and rather unexpected finding was the relaxinrelated benefit in terms of 180 day mortality, with an improvement from 9.6 to 6.1% for cardiovascular and from 11.3 to 7.3% for all-cause mortality and a number needed to treat of approximately 25.</s><s>The safety analysis showed a significant decrease in systolic BP at different time points (by 4-6 mmHg), more frequent dose modifications (29 vs. 18%), but similar rates of hypotensive adverse events and no systolic BP rebound after drug cessation in the serelaxin, as compared with the placebo, group.</s><s>Of note, a combined analysis of the Pre-RELAX and RELAX trials <ref type="bibr" target="#b160">(Teerlink et al., 2009;</ref><ref type="bibr" target="#b159">Teerlink et al., 2013)</ref> suggests that relaxin primarily reduced deaths classified as 'non-HF cardiovascular cause' and 'sudden death', though this conclusion is merely hypothesis generating, because of the overall small number of events <ref type="bibr" target="#b67">(Greene and Gheorghiade, 2014)</ref>.</s><s>As RELAX-AHF was not powered to detect mortality differences, a second and larger mortality trial in AHF patients is underway.</s></p><p><s>The encouraging results obtained in RELAX were also corroborated in the (much smaller) Japanese Serelaxin trial <ref type="bibr" target="#b151">(Sato et al., 2015)</ref> underlining the efficacy of the peptide in an Asian population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Current knowledge gaps</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mechanism of 48 h treatments having effects after 180 days</head><p><s>Certainly, the study design of RELAX considered the lessons from the many failed AHF studies by enrolling earlier after AHF onset and by focusing exclusively on patients with rather high BP.</s><s>But what are the critical roles of relaxin in reversing or reducing damage associated with HF?</s><s>The rather moderate and self-limiting effect on BP should be considered because it is most likely to prevent renal adverse events <ref type="bibr" target="#b65">(Gheorghiade et al., 2006;</ref><ref type="bibr" target="#b168">Voors et al., 2011)</ref>.</s></p><p><s>With regard to signal transduction, it is worth mentioning the inhibitory effect of relaxin on ET-1 that has a pivotal role in AHF-related systemic and pulmonary afterload mismatch, neurohumoral activation and inflammation <ref type="bibr" target="#b169">(Webb, 1995;</ref><ref type="bibr" target="#b157">Stangl et al., 2000;</ref><ref type="bibr" target="#b95">Kawanabe and Nauli, 2011)</ref>.</s><s>Relaxin inhibits the stimulation of ET-1 release, reduces ET-1 gene expression, promotes endothelial expression of its clearance receptor, ET B , and acts thereby as a functional ET-1 antagonist <ref type="bibr">(Dschietzig et al., 2001a,b;</ref><ref type="bibr" target="#b42">Dschietzig et al., 2003)</ref>.</s><s>Also, activation of the cGMP-PKG pathway is highly beneficial in many pathological cardiovascular states <ref type="bibr" target="#b134">(Paulus and Tschope, 2013)</ref>.</s><s>Relaxin feeds into this pathway at many points, by stimulating NO production and/or NOS expression <ref type="bibr" target="#b7">(Bani et al., 1998a;</ref><ref type="bibr" target="#b4">Alexiou et al., 2013)</ref> and by increasing NO bioavailability through its anti-inflammatory <ref type="bibr" target="#b115">(Masini et al., 2004;</ref><ref type="bibr" target="#b19">Brecht et al., 2011)</ref>, antioxidant and endothelium-protective actions <ref type="bibr" target="#b44">(Dschietzig et al., 2012)</ref>.</s></p><p><s>The anti-fibrotic effects of relaxin may play a role in organ protection, and reversal of established cardiac fibrosis by relaxin is desirable particularly in patients with HF with preserved ejection fraction (Figure <ref type="figure">5</ref>).</s><s>The peptide also exerts a broad range of vascular and organ-protective <ref type="bibr" target="#b4">(Alexiou et al., 2013;</ref><ref type="bibr" target="#b25">Collino et al., 2013)</ref> actions mediated mainly via NO and the glucocorticoid receptors <ref type="bibr" target="#b43">(Dschietzig et al., 2004;</ref><ref type="bibr" target="#b44">Dschietzig et al., 2012)</ref>.</s><s>Numerous in vitro and in vivo studies show cardiac protection following brief administration of relaxin against acute injury due to ischaemia, oxidative stress, inflammation or drug toxicity <ref type="bibr" target="#b48">(Du et al., 2014)</ref>.</s><s>That these factors precipitate cardiac decompensation or acute worsening of HF has been well established <ref type="bibr" target="#b30">(Cotter et al., 2010;</ref><ref type="bibr" target="#b87">Januzzi et al., 2012;</ref><ref type="bibr" target="#b121">Metra et al., 2013a)</ref>.</s><s>Thus, the cardiac protective property of relaxin might result in suppression of reactive and/or reparative fibrosis (Figure <ref type="figure">5</ref>).</s></p><p><s>A key finding in the RELAX-AHF trial is that the dynamic changes in the first couple of days of biomarkers that reflect damage of multiple organs (heart, kidney and liver) and have predictive value for 180 day prognosis in patients with acute decompensated HF (ADHF) are reduced by relaxin <ref type="bibr" target="#b121">(Metra et al., 2013a)</ref>.</s><s>In fact, in addition to these pivotal organs, there is also evidence for damage or malfunction of other organs such as intestine, lung and skeletal muscle, in the setting of ADHF <ref type="bibr" target="#b135">(Peschel et al., 2003;</ref><ref type="bibr" target="#b103">Lauten et al., 2011;</ref><ref type="bibr">Hogan et al., 2012a,b)</ref>.</s><s>Thus, we suggest that a compromised tissue microcirculation underlies the multiple organ damage or malfunction <ref type="bibr" target="#b48">(Du et al., 2014)</ref>.</s><s>Considering the present strong evidence for organ and endothelial protection by relaxin in a variety of disease settings <ref type="bibr" target="#b48">(Du et al., 2014)</ref>, we find it likely that damage and dysfunction of the microvasculature in many organs in response to acute decompensation of HF are also exacerbated in clinical conditions following ADHF.</s><s>In this context, acute relaxin administration protects against microvascular injury, poor microcirculation and organ damage.</s><s>The amelioration of organ damage and dysfunction by short-term administration of relaxin would affect long-term prognosis by limitation of cardiovascular injury and reduction of reparative and reactive fibrosis (Figure <ref type="figure">5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Role of venodilation by relaxin in treating AHF</head><p><s>The effects of relaxin on the venous circulation could potentially account for the haemodynamic effects of relaxin in AHF and CHF.</s><s>One recent study in rat mesenteric veins showed that, in contrast to arteries, they are not remodelled and do not show reduced myogenic reactivity in response to relaxin <ref type="bibr" target="#b108">(Li et al., 2005;</ref><ref type="bibr" target="#b89">Jelinic et al., 2014)</ref>.</s><s>Both studies were performed in vitro and may have been influenced by venous tone being significantly more dependent than arterial tone on sympatho-adrenergic innervation and pacemaker cells (Cajal cells) <ref type="bibr" target="#b64">(Gelman, 2008)</ref>.</s><s>Contraction of splanchnic veins by relaxin (as seen in pregnancy; <ref type="bibr" target="#b155">Slangen et al., 1996;</ref><ref type="bibr" target="#b51">Edouard et al., 1998)</ref> or dilation of central veins would increase venous return and explain the baseline-dependent, 'self-limiting' drop of BP observed in AHF and CHF patients treated with</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 5</head><p><s>Therapeutic potential of serelaxin in heart disease and HF.</s><s>Relaxin therapy mediates fibrosis reversal in rodent models of cardiac fibrosis.</s><s>There is also strong experimental evidence and clinical evidence for the cardiac protective property of relaxin against factors that function as triggers for cardiac decompensation or acute worsening of HF.</s><s>These actions would be expected to ameliorate cardiac fibrosis.</s></p><p><s>relaxin.</s><s>The issue is therefore still open for interesting and important investigations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Anti-arrhythmic potential</head><p><s>Reduction of 180 day mortality by relaxin treatment was observed in the RELAX-AHF trial <ref type="bibr" target="#b159">(Teerlink et al., 2013)</ref>.</s><s>With some of the sudden deaths likely to be attributable to arrhythmias <ref type="bibr" target="#b55">(Felker et al., 2014)</ref>, there is emerging evidence for an antiarrhythmic action of relaxin.</s><s>In an elderly SHR model <ref type="bibr" target="#b133">(Parikh et al., 2013)</ref>, relaxin (0.5 mg • kg À1 • day À1 ) over 2 weeks followed by programmed electrical stimulation of the isolated atria reduced atrial fibrillation, an effect associated with significant reduction in atrial fibrosis and increased Na + current density <ref type="bibr" target="#b133">(Parikh et al., 2013)</ref>.</s><s>It has been suggested that there is a reciprocal influence between HF and arrhythmias and that arrhythmias act as a facilitating factor for decompensation or worsening of HF <ref type="bibr" target="#b50">(Dukes et al., 2015;</ref><ref type="bibr" target="#b101">Kotecha and Piccini, 2015)</ref>.</s><s>Fibrosis reversal and anti-arrhythmic effects are observed after relaxin for 14 days, although it is not known if this could be achieved by a 48 h treatment.</s><s>Further studies are necessary to explore the time course of anti-fibrotic and potentially antiarrhythmic actions by relaxin either as a monotherapy or in conjunction with other cardiac medications.</s></p><p><s>There is also evidence that suggests that relaxin influences myoendothelial coupling in humans.</s><s>Gap junctions play an important role in vessel structure, function and therefore myoendothelial coupling.</s><s>Gap junctions are composed of connexin (Cx) proteins, and in the cardiovascular system, the main connexins expressed are Cx40, Cx37, Cx43 and Cx45 (de <ref type="bibr" target="#b33">Wit et al., 2008)</ref>.</s><s>Relaxin increases the expression of Cx43 in several tissues, including mouse neonatal immature cardiomyocytes, rodent cardiomyocytes and skeletal myoblasts <ref type="bibr" target="#b60">(Formigli et al., 2005)</ref> and hearts from SHR <ref type="bibr" target="#b133">(Parikh et al., 2013)</ref>.</s><s>There is also a role of Cx proteins in cellular crosstalk because relaxin promotes the coupling between mouse skeletal muscle myoblasts and adult rat ventricular cardiomyocytes in an in vitro co-culture model that involves Cx43, suggesting a potential role for gap junction communication that is enhanced by relaxin <ref type="bibr" target="#b60">(Formigli et al., 2005)</ref>.</s><s>Thus, there is a need to thoroughly investigate the effects of relaxin on myoendothelial coupling to better understand its cardiovascular effects in humans.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Regulation of RXFP1 receptors or of relaxin in the cardiovascular system under diseased conditions</head><p><s>Endogenous expression of relaxin is elevated in heart disease <ref type="bibr" target="#b46">(Dschietzig et al., 2001b;</ref><ref type="bibr" target="#b173">Xu et al., 2008)</ref> although the extent of up-regulation seems insufficient to exert compensatory action <ref type="bibr" target="#b173">(Xu et al., 2008)</ref>.</s><s>Regulation of relaxin expression is poorly defined.</s><s>The rat relaxin gene promoter region contains guanine (G)-rich repeats, allowing formation of G-quadruplexes that can be stabilized by ligands such as berberine <ref type="bibr" target="#b68">(Gu et al., 2012)</ref>.</s><s>These sequences are adjacent to the binding motif of STAT3 that negatively regulates relaxin expression.</s><s>In cardiac fibroblasts and in rats treated with Ang II, berberine suppressed fibroblast activation, collagen synthesis and cardiac fibrosis by up-regulating relaxin <ref type="bibr" target="#b68">(Gu et al., 2012)</ref>.</s></p><p><s>There is limited information on gene regulation of RXFP1 receptors in disease.</s><s>The expression of RXFP1 receptors is moderately decreased in failing human myocardium <ref type="bibr" target="#b37">(Dschietzig et al., 2011)</ref>.</s><s>In reproductive tissues, expression of RXFP1 receptors is up-regulated by oestrogen and progesterone <ref type="bibr" target="#b174">(Yan et al., 2008;</ref><ref type="bibr" target="#b166">Vodstrcil et al., 2010)</ref>, but oestrogen treatment has no effect or may even reduce expression in atria <ref type="bibr" target="#b158">(Tan et al., 1999)</ref>.</s><s>It remains unknown whether expression of RXFP1 receptors in the cardiovascular system is gender-dependent or varies during pregnancy.</s><s>While mRNA for RXFP1 receptors was up-regulated in the infarcted rat heart <ref type="bibr" target="#b100">(Kompa et al., 2002)</ref>, expression of these receptors was unchanged in a mouse model of chronic pressure overload <ref type="bibr" target="#b173">(Xu et al., 2008)</ref>.</s><s>The expression of RXFP1 receptors in cultured cardiomyocytes or intact heart is down-regulated by activation of β 1 -adrenoceptors but up-regulated by activation of α 1 -AR <ref type="bibr" target="#b125">(Moore et al., 2014)</ref>.</s><s>This may influence the efficacy of serelaxin in patients treated with β-blockers.</s><s>This was not observed in the RELAX-AHF trial <ref type="bibr" target="#b121">(Metra et al., 2013a)</ref>, perhaps due to small sample size.</s><s>This question, however, could be addressed in the current RELAX-AHF2 trial.</s></p><p><s>Could the standard therapy given to patients in RELAX-AHF be confounding the results, that is, could ACE inhibitors/AT receptor antagonists /β-blockers affect the response to relaxin?</s></p><p><s>The pleiotropic actions of relaxin make it unique in AHF therapy.</s><s>Cardiac remodelling is fundamental in heart disease and failure, and several key factors emerge regardless of aetiology including hypertrophy, inflammation, interstitial fibrosis and continuous loss of cardiomyocytes.</s><s>These components orchestrate functional decline and development of complications, thereby influencing short-and long-term prognosis of AHF.</s><s>In theory, changes in some of these key components would be expected to have a beneficial influence on patients with AHF and thus confound the effects of relaxin.</s><s>On the other hand, ACE inhibitors, Ang II receptor antagonists and β-blockers have not been shown to be effective in AHF.</s></p><p><s>The evidence that RXFP1 receptors form heterodimers with the Ang II AT 2 receptor and that these are essential for the anti-fibrotic effects of relaxin in the kidney <ref type="bibr" target="#b24">(Chow et al., 2014)</ref> raises important questions that are relevant to its clinical use.</s><s>The anti-fibrotic effects of relaxin are completely lost in mice treated with the AT 2 receptor antagonist PD123319 or in AT 2 receptor KO mice.</s><s>These findings provide an explanation for the observation that the anti-fibrotic effects of relaxin are only seen in pathological conditions, with no effect on normal tissue.</s><s>AT 2 receptors are typically expressed at very low levels in healthy tissue, but their expression dramatically increases after injury or disease <ref type="bibr" target="#b118">(Matsubara, 1998;</ref><ref type="bibr" target="#b22">Carey, 2005)</ref>.</s><s>RXFP1 receptors are also poorly expressed at the cell surface, but at higher levels within the ER <ref type="bibr" target="#b97">(Kern et al., 2007)</ref>.</s><s>Enhanced heterodimerization facilitated by the injury-induced increase in AT 2 receptor expression may increase trafficking of RXFP1 receptors (as an AT 2 -RXFP1 receptor heterodimer) to the cell surface, thus explaining why relaxin treatment is more effective under pathological conditions.</s><s>While the AT 2 receptor is not currently regarded as a therapeutic target, there is emerging evidence that the RXFP1 receptor forms heterodimers with other GPCRs that are therapeutically important.</s><s>It is also interesting to note that, in an earlier study, arteries obtained from patients on ACE inhibitors showed marked attenuation of the vasodilator response to relaxin, effects that appeared to be further enhanced by inhibition of COX <ref type="bibr" target="#b58">(Fisher et al., 2002)</ref>.</s><s>However, patients not receiving ACE inhibitors showed little effect of inhibition of COX on the response to relaxin <ref type="bibr" target="#b58">(Fisher et al., 2002)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>After a long gestation period, the peptide hormone relaxin is now emerging as an effective treatment for AHF.</s><s>Although a great deal is now known regarding the cellular actions of relaxin, it is still far from clear which of its pleiotropic effects vasodilation, anti-fibrotic, angiogenic, anti-apoptotic or anti-inflammatoryis responsible for the beneficial effects.</s><s>This review has summarized current knowledge of the cardiovascular effects of relaxin, identified knowledge gaps and has suggested possible mechanisms of action.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="3,311.81,418.51,239.74,259.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="3,48.93,56.98,227.45,423.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="5,140.88,56.98,312.41,332.16" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 935</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 937</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">M Sarwar et al.   </note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 941</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 943</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 945</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 947</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2017) 174 933-949 949</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>T.B.D. was supported by grants 89874634 and 89844575 from BAS Medical Inc. and grants KF2181501AJ9 and KF2318301 from Zentrales Innovationsprogramm Mittelstand.</s><s>R.J.S was supported by NHMRC Programme grant 1055134 and ARC Linkage grant LP110100288.</s><s>X.J.D. was supported by NHMRC fellowship (1043026) and project grants (1004235 and 1081710).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>The authors declare no conflicts of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Relaxin induces matrixmetalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-zeta pathways</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kapila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="46" to="61" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The Concise Guide to PHARMACOLOGY 2015/16: Enzymes</title>
		<author>
			<persName><forename type="first">Sph</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fabbro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Marrion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="6024" to="6109" />
			<date type="published" when="2015">2015a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The Concise Guide to PHARMACOLOGY 2015/16: G Protein-Coupled Receptors</title>
		<author>
			<persName><forename type="first">Sph</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Davenport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Marrion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="5744" to="5869" />
			<date type="published" when="2015">2015b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors</title>
		<author>
			<persName><forename type="first">Sph</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cidlowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Marrion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="5956" to="5978" />
			<date type="published" when="2015">2015c</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Relaxin protects rat lungs from ischemia-reperfusion injury via inducible NO synthase: role of ERK-1/2, PI3K, and forkhead transcription factor FKHRL1</title>
		<author>
			<persName><forename type="first">K</forename><surname>Alexiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wilbring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e75592</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Inhibitory effects of relaxin on human basophils activated by stimulation of the Fc epsilon receptor. The role of nitric oxide</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baronti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vannacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Sacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Mannaioni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Immunopharmacol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1195" to="1204" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Sacchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="709" to="716" />
			<date type="published" when="1995">1995a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Failli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thiemermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bani</forename><surname>Sacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1240" to="1247" />
			<date type="published" when="1998">1998a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Sacchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="5272" to="5275" />
			<date type="published" when="1995">1995b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Sacchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="1367" to="1376" />
			<date type="published" when="1998">1998b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Bani-Sacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Mannaioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Relaxin-induced increased coronary flow through stimulation of nitric oxide production</title>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="1589" to="1594" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Relaxin family peptides and their receptors</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Halls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Van Der Westhuizen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Callander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kocan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="405" to="480" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Lekgabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Mcguane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ferraro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="30" to="38" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Relaxin and its role in the development and treatment of fibrosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Bennett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transl Res</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bitto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Irrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Minutoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Calo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lo</forename><surname>Cascio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Caccia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Sci</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="575" to="585" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway</title>
		<author>
			<persName><forename type="first">G</forename><surname>Boccalini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sassoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Formigli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="239" to="249" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Relaxin treatment reverses insulin resistance in mice fed a high-fat diet</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Bonner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lantier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Hocking</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Owolabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>James</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="3251" to="3260" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Cardiorenal syndrome-current understanding and future perspectives</title>
		<author>
			<persName><forename type="first">B</forename><surname>Braam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Joles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Danishwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Gaillard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Nephrol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="48" to="55" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Brecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Relaxin inhibits early steps in vascular inflammation</title>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="76" to="82" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Involvement of extracellular signalregulated kinases 1/2 in cardiac hypertrophy and cell death</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">F</forename><surname>Bueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Molkentin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="776" to="781" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="840" to="844" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMPdependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Chew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e42714</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kocan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bosnyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sarwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="75" to="85" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury</title>
		<author>
			<persName><forename type="first">M</forename><surname>Collino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rogazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Benetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Rosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chiazza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Mol Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1494" to="1505" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Debrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Shroff</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats</title>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="3289" to="3296" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Emerging role of relaxin in renal and cardiovascular function</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="R250" to="R261" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Effects of relaxin on arterial dilation, remodeling, and mechanical properties</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Shroff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Hypertens Rep</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="409" to="420" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Acute heart failure clinical drug development: from planning to proof of activity to phase III</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Weatherley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Pang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Teerlink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiology</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="292" to="301" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Coulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Thorp</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Cefalo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="610" to="612" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Relaxin is a potent renal vasodilator in conscious rats</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="525" to="533" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Signaling across myoendothelial gap junctions-fact or fiction?</title>
		<author>
			<persName><forename type="first">C</forename><surname>De Wit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boettcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Schmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Commun Adhes</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="231" to="245" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Debrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Shroff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="1013" to="1020" />
			<date type="published" when="2005">2005a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Debrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jeyabalan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Shroff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="745" to="750" />
			<date type="published" when="2005">2005b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Debrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Shroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="5126" to="5131" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The positive inotropic effect of relaxin-2 in human atrial myocardium is preserved in end-stage heart failure: role of G(i)-phosphoinositide-3 kinase signaling</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alexiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Kinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="158" to="166" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="77" to="84" />
			<date type="published" when="2009">2009a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m">Myocardial relaxin counteracts hypertrophy in hypertensive rats</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1041</biblScope>
			<biblScope unit="page" from="441" to="443" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kB</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="32" to="40" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1536" to="1538" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Relaxin improves TNF-alpha-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alexiou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="97" to="107" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bohme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Heinze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="245" to="251" />
			<date type="published" when="2001">2001a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The pregnancy hormone relaxin is a player in human heart failure</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Armbruster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="2187" to="2195" />
			<date type="published" when="2001">2001b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Teichman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="182" to="190" />
			<date type="published" when="2009">2009b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Therapeutic effects of serelaxin in acute heart failure</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="542" to="552" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Parry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Tregear</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="395" to="404" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Ventricular ectopy as a predictor of heart failure and death</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dukes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Dewland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vittinghoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mandyam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Heckbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Siscovick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="101" to="109" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Edouard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Pannier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>London</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Cuche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Safar</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Venous and arterial behavior during normal pregnancy</title>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="H1605" to="H1612" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure</title>
		<author>
			<persName><forename type="first">T</forename><surname>Eschenhagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Mende</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Scholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haverich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="688" to="696" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells</title>
		<author>
			<persName><forename type="first">P</forename><surname>Failli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mazzetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Sacchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="252" to="254" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Felker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Teerlink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cotter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1591" to="1598" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fernandez-Patron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Radomski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Davidge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="906" to="911" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fernandez-Patron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Koivunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Radomski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Davidge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="670" to="676" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Morecroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Seed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hillier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="292" to="295" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<title level="m" type="main">Relaxin: a new cardiovascular hormone in humans? Comparative potency and mechanisms of action</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Fisher</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
		<respStmt>
			<orgName>MD thesis Dept Medicine and Therapeutics. Glasgow University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment</title>
		<author>
			<persName><forename type="first">L</forename><surname>Formigli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Francini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Squecco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Polidori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="C795" to="C804" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling</title>
		<author>
			<persName><forename type="first">L</forename><surname>Formigli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Perna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cinci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Margheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Mol Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1087" to="1100" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Effect of relaxin in two models of renal mass reduction</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Garber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mirochnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brecklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Slobodskoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Arruda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dunea</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Nephrol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="8" to="12" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Relaxin decreases renal interstitial fibrosis and slows progression of renal disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Garber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mirochnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Brecklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Slobodskoy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="876" to="882" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Venous function and central venous pressure: a physiologic story</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gelman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="735" to="748" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gheorghiade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>She</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="page" from="2217" to="2226" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Enhanced uterine artery stiffness in aged pregnant relaxin mutant mice is reversed with exogenous relaxin treatment</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Gooi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jelinic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Girling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wlodek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tare</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page">18</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized heart failure</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gheorghiade</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1599" to="1601" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Upregulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="3692" to="3700" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Relaxin does not improve angiotensin II-induced target-organ damage</title>
		<author>
			<persName><forename type="first">N</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rugor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Przybyl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Qadri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e93743</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Halls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="214" to="226" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Halls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Sutton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Rev</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="389" to="440" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Relaxin activates multiple cAMP signaling pathway profiles in different target cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Halls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1160</biblScope>
			<biblScope unit="page" from="108" to="111" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Relaxin increases heart rate by modulating calcium current in cardiac pacemaker cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Habuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Giles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="537" to="541" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway</title>
		<author>
			<persName><forename type="first">Mhj</forename><surname>Heeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Koziolek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vasko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Muller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="96" to="109" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Relaxin-induced matrix metalloproteinase-9 expression is associated with activation of the NF-kB pathway in human THP-1 cells</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Y</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Bagnell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1303" to="1310" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Franzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rajendran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Thacker</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure</title>
	</analytic>
	<monogr>
		<title level="j">Am J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="872" to="880" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Kontos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Thacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pittman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Peripheral tissue oxygenation improves during ED treatment of acute heart failure</title>
	</analytic>
	<monogr>
		<title level="j">Am J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="196" to="202" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Relaxin modulates proinflammatory cytokine secretion from human decidual macrophages</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Horton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Bryant-Greenwood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="788" to="797" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hossain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Man</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Wade</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1368" to="1375" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Houslay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Baillie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Maurice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="950" to="966" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Activation of orphan receptors by the hormone relaxin</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kumagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="page" from="671" to="674" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Systemic administration of recombinant human relaxin (RHRLX) ameliorates the acute cyclosporine nephrotoxicity in rats</title>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sunga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zsebo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Heart Lung Transplant</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">253</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Thannickal</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Relaxin regulates myofibroblast contractility and protects against lung fibrosis</title>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="2751" to="2765" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Januzzi</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nieminen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gheorghiade</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section</title>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2265" to="2271" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykininmediated relaxation after in vivo serelaxin treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jelinic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Post</forename><surname>Uiterweer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Sandow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Gooi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Wlodek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="275" to="287" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Differential effects of relaxin deficiency on vascular aging in arteries of male mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jelinic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Parry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Age</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page">9803</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Essential role for vascular gelatinase activity in relaxininduced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jeyabalan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kerchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Opett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1249" to="1257" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Conditional deletion of the relaxin receptor gene in cells of smooth muscle lineage affects lower reproductive tract in pregnant mice</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Kaftanovskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Agoulnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page">91</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Cardiac effects of relaxin in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kakouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Eddie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="1076" to="1078" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kapila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Orthod Craniofac Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="178" to="186" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Nauli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endothelin. Cell Mol Life Sci</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="195" to="203" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Evidence against the hypothesis that endothelial endothelin B receptor expression is regulated by relaxin and pregnancy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kerchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hanley-Yanez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Doty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="2791" to="2797" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Agoulnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Bryant-Greenwood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="1181" to="1194" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Signalling specificity in GPCR-dependent Ca2+ signalling</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kiselyov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muallem</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Signal</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="243" to="253" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">No-reflow phenomenon: maintaining vascular integrity</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Kloner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="244" to="250" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Kompa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="710" to="718" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Atrial fibrillation in heart failure: what should we do?</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kotecha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Piccini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="3250" to="3257" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Impaired nipple development and parturition in LGR7 knockout mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Krajnc-Franken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Disseldorp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Koenders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mosselman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Duin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gossen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="687" to="696" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Microvascular tissue perfusion is impaired in acutely decompensated heart failure and improves following standard treatment</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lauten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Goebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rademacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schumm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Uth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="711" to="717" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">The extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Fields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="511" to="518" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Lekgabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiriazis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Su</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="412" to="418" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">A vasoactive role for endogenous relaxin in mesenteric arteries of male mice</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jelinic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Gooi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Parry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e107382</biblScope>
			<date type="published" when="2014">2014a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jelinic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Parkington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Parry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e000493</biblScope>
			<date type="published" when="2014">2014b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Acute and chronic effects of relaxin on vasoactivity, myogenic reactivity and compliance of the rat mesenteric arterial and venous vasculature</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">L</forename><surname>Brookes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaufman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="41" to="46" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Relaxin has anti-apoptotic effects on human trophoblast-derived HTR-8/SV neo cells</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Lodhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hazama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ebina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1051" to="1054" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Zang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Xi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1102" to="1109" />
			<date type="published" when="2013">2013a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Kalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plautz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename></persName>
		</author>
		<author>
			<persName><forename type="first">-M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Relaxin promotes in vitro tumour growth, invasion and angiogenesis of human Saos-2 osteosarcoma cells by AKT/VEGF pathway</title>
	</analytic>
	<monogr>
		<title level="j">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1345" to="1350" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide</title>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Mannaioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Sacchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="4713" to="4720" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Relaxin inhibits histamine release from mast cells: involvement of nitric oxide production</title>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Bani</forename><surname>Sacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mannaioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S12" to="S13" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway</title>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vannacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bani</forename><surname>Sacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Novelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="1106" to="1112" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway</title>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zagli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ndisang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Solazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Mannaioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="337" to="344" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro</title>
		<author>
			<persName><forename type="first">R</forename><surname>Masterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kelynack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Parry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bathgate</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="544" to="552" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases</title>
		<author>
			<persName><forename type="first">H</forename><surname>Matsubara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="1182" to="1191" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Mcguane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Debrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1151" to="1160" />
			<date type="published" when="2011">2011a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Mcguane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Debrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sautina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Jarajapu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="2786" to="2796" />
			<date type="published" when="2011">2011b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Metra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Davison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Felker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="196" to="206" />
			<date type="published" when="2013">2013a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF</title>
		<author>
			<persName><forename type="first">M</forename><surname>Metra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Davison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Felker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3128" to="3136" />
			<date type="published" when="2013">2013b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Inhibition of RET tyrosine kinase by SU5416</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mologni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cazzaniga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rostagno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kuoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Puttini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="199" to="212" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2</title>
		<author>
			<persName><forename type="first">I</forename><surname>Mookerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Halls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mathai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1219" to="1229" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Diverse regulation of cardiac expression of relaxin receptor by α1-and β1-adrenoceptors</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Woodcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Drugs Ther</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="221" to="228" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="1582" to="1589" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jelinic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Parry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Leo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="H285" to="H296" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Relaxin stimulates cAMP production in MCF-7 cells upon overexpression of type V adenylyl cyclase</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Dessauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1041</biblScope>
			<biblScope unit="page" from="296" to="299" />
			<date type="published" when="2005">2005a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Relaxin stimulates protein kinase C z translocation: requirement for cyclic adenosine 3′,5′-monophosphate production</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Dessauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1012" to="1023" />
			<date type="published" when="2005">2005b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cinci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Perna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mastroianni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Res</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="43" to="48" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Relaxin is essential for renal vasodilation during pregnancy in conscious rats</title>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Danielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kerchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Moalli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="1469" to="1475" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Relaxin binding in the rat heart atrium</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Osheroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cronin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Lofgren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="2384" to="2388" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts</title>
		<author>
			<persName><forename type="first">A</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Mctiernan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Haney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="313" to="321" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Paulus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschope</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="263" to="271" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure</title>
		<author>
			<persName><forename type="first">T</forename><surname>Peschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schonauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thiele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Niebauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="609" to="614" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">A randomized, double-blind, placebocontrolled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mitrovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vishnevsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="431" to="441" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chiappini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Scapagnini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bigazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bani</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture</title>
	</analytic>
	<monogr>
		<title level="j">Mol Hum Reprod</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="325" to="330" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bodaragama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Chew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Widdop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Royce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="315" to="322" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Relaxin remodels fibrotic healing following myocardial infarction</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cendrawan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiriazis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="675" to="690" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Kelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="3286" to="3293" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Lekgabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mookerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">612</biblScope>
			<biblScope unit="page" from="88" to="103" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Physiological or pathological-a role for relaxin in the cardiovascular system?</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Parry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="152" to="158" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mookerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Layfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="4125" to="4133" />
			<date type="published" when="2004">2004a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Relaxin-1-deficient mice develop an age-related progression of renal fibrosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hewitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Amento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="2054" to="2064" />
			<date type="published" when="2004">2004b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Sarwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells</title>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="484" to="496" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Sarwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Serelaxin-mediated signal transduction in human vascular cells: bellshaped concentration-response curves reflect differential coupling to G proteins</title>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="1005" to="1019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(omega)-nitro-L-arginine methyl ester hypertensive rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Molnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Baylis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="197" to="204" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Multicenter, randomized, double-blinded, placebocontrolled phase II study of serelaxin in Japanese patients with acute heart failure</title>
		<author>
			<persName><forename type="first">N</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hirayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ajioka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Okishige</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="1237" to="1247" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Segal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sautina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Diao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Agoulnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kielczewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="629" to="636" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">Relaxin alters cardiac myofilament function through a PKCdependent pathway</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kulpa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Summerlee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Pyle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="H29" to="H36" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Relaxin&apos;s physiological roles and other diverse actions</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="205" to="234" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">Hemodynamic changes in early pregnancy in chronically instrumented, conscious rats</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Slangen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Out</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Verkeste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Peeters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="H1779" to="H1784" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands</title>
		<author>
			<persName><forename type="first">C</forename><surname>Southan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sharman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Faccenda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sph</forename><surname>Alexander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucl Acids Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="D1054" to="D1068" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dschietzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tanis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="1132" to="1138" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Tregear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="91" to="98" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebocontrolled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Teerlink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Davison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Felker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="page" from="29" to="39" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebocontrolled, parallel-group, dose-finding phase IIb study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Teerlink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Metra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Felker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Weatherley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="1429" to="1439" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Relaxin stimulates atrial natriuretic peptide secretion in perfused rat heart</title>
		<author>
			<persName><forename type="first">M</forename><surname>Toth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Taskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ruskoaho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="487" to="495" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Erikson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Rocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Sutherland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Parsell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Reprod</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="800" to="806" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ferrara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Amento</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="557" to="562" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Constant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Grove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Normand</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Wound Repair Regen</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="361" to="370" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Pickford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Salles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Piercy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Grove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Erikson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="2739" to="2745" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Progesterone withdrawal, and not increased circulating relaxin, mediates the decrease in myometrial relaxin receptor (RXFP1) expression in late gestation in rats</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Vodstrcil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Shynlova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Westcott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Laker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wlodek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="825" to="832" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">Renal hemodynamic effects of serelaxin in patients with chronic heart failure: a randomized, placebo-controlled study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dahlke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stepinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Heart Fail</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="994" to="1002" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Davison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Felker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Unemori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cotter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="961" to="967" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Endothelin antagonism in heart failure</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Webb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page">3372</biblScope>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Benyon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Trim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hadwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Grove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Arthur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="577" to="583" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Saleh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">393</biblScope>
			<biblScope unit="page" from="160" to="164" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chakravorty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bathgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1260" to="1266" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Lekgabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Tregear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="476" to="482" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">Relaxin (RLX) and estrogen affect estrogen receptor alpha, vascular endothelial growth factor, and RLX receptor expression in the neonatal porcine uterus and cervix</title>
		<author>
			<persName><forename type="first">W</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Wiley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Crean-Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Bartol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Bagnell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Reproduction</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="705" to="712" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Agoulnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Cooke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Meling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">Relative roles of the epithelial and stromal tissue compartment(s) in mediating the actions of relaxin and estrogen on cell proliferation and apoptosis in the mouse lower reproductive tract</title>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1160</biblScope>
			<biblScope unit="page" from="121" to="129" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">Relaxin protects against renal ischemia-reperfusion injury</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kumagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kohsaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ikegaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="F1169" to="F1176" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Relaxin ameliorates salt-sensitive hypertension and renal fibrosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kumagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ohkawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Odamaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2190" to="2197" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">Effect of relaxin on myocardial ischemia injury induced by isoproterenol</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Geng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1632" to="1639" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main">Relaxin activates the MAP kinase pathway in human endometrial stromal cells</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Erikson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Unemori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="536" to="544" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes</title>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochimie</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="59" to="67" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main">Mice without a functional relaxin gene are unable to deliver milk to their pups</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gunnersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>Hammond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Tregear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wintour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="445" to="453" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Samuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Tregear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wintour</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Collagen studies in late pregnant relaxin null mice</title>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="697" to="703" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
